John A. Kalapurakal

John A. Kalapurakal

Auto-generated profile, based on publicly available information

John A. Kalapurakal

Neuroradiology Section, Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2017 in Journal of Neurological Surgery Part B: Skull Base
Verified
Journal Article
Closed access
PDF file
TRTamer Refaat
Tamer Refaat
MGMichelle Gentile
Michelle Gentile
SSSean Sachdev
Sean Sachdev
PDPrarthana Dalal
Prarthana Dalal
ABAnish Butala
Anish Butala
JKJohn A. Kalapurakal
John A. Kalapurakal
Purpose This study aims to report long-term clinical outcomes after Gamma Knife radiosurgery (GKRS) for intracranial grade 2 meningiomas. Methods In this Institutional Review Board approved study, we reviewed records of all patients with grade 2 meningiomas treated with GKRS between 1998 and 2014. Results A total of 97 postoperative histopathologically confirmed grade 2 meningiomas in 75 patients were treated and are included in this study. After a mean follow-up of 41 months, 28 meningiomas had local recurrence (29.79%). Median time to local recurrence was 89 months (mean: 69, range: 47–168). The 3- and 5-year actuarial local control (LC) rates were 68.9 and 55.7%, respectively. The 3- and 5-year overall survival rates were 88.6 and 81.1%, respectively. There was a trend toward worse LC with tumors treated with radiation doses ≤ 13 versus > 13 Gy. There was no radiation necrosis or second malignant tumors noted in our series. Conclusion This report, one of the largest GKRS series for grade 2 meningiomas, demonstrates that GKRS is a safe and effective treatment modality for patients with grade 2 meningiomas with durable tumor control and minimal toxicity. Adjuvant GKRS could be considered as a reasonable treatment approach for patients with grade 2 meningiomas.

10 October 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SDSalah Dajani
Salah Dajani
VHVirginia Boyce Hill
Virginia Boyce Hill
JKJohn A. Kalapurakal
John A. Kalapurakal
CHCraig M. Horbinski
Craig M. Horbinski
ENEric G. Nesbit
Eric G. Nesbit
TTTarita O Thomas
Tarita O Thomas
Glioblastoma (GBM) continues to be one of the most lethal malignancies and is almost always fatal. In this review article, the role of radiation therapy, systemic therapy, as well as the molecular basis of classifying GBM is described. Technological advances in the treatment of GBM are outlined as well as the diagnostic imaging characteristics of this tumor. In addition, factors that affect prognosis such as differentiating progression from treatment effect is discussed. The role of MRI guided radiation therapy and how this technology may provide a mechanism to improve the care of patients with this disease are described.